SAFETY ALERT: Risk of Cardiovascular Death with Zithromax – Monthly Prescribing Reference

In 2011, FDA reviewed macrolide drug labeling information related to QT interval prolongation and torsades de pointes. The Warnings and Precautions section of the Zmax drug label (azithromycin extended-release for oral suspension) was revised in March 2012 …

Leave a Reply

Your email address will not be published. Required fields are marked *